피부 생검 시장 규모, 점유율, 성장 분석(유형별, 적응증별, 최종사용자별, 지역별) : 산업 예측(2025-2032년)

Global Skin Biopsy Market size was valued at USD 31.9 billion in 2023 and is poised to grow from USD 35.3 billion in 2024 to USD 80.29 billion by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

The skin biopsy market is poised for significant growth, spurred by advancing healthcare infrastructure in emerging markets, an uptick in global skin cancer cases, and rising demand for sophisticated healthcare services. An increase in melanoma cases, particularly in the United States, has escalated the need for diagnostic skin biopsies, which are also vital for identifying conditions like dermatitis and psoriasis. Government investments in healthcare and the expansion of medical tourism in developing nations further amplify market potential. Patient preference is shifting towards less invasive medical procedures, directly elevating biopsy demand. Nonetheless, challenges such as high procedural costs and limited awareness of innovative techniques may impede growth. As technological advancements unfold, coupled with greater health consciousness and spending, the market is set for a promising future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Skin Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Skin Biopsy Market Segmental Analysis

Global Skin Biopsy Market is segmented by type, indication, end user and region. Based on type, the market is segmented into shave biopsy, punch biopsy and excisional biopsy. Based on indication, the market is segmented into skin cancer, actinic keratosis, dermatitis and others. Based on end user, the market is segmented into hospital, clinics, diagnostic laboratories and other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Skin Biopsy Market

The global skin biopsy market is significantly driven by advancements in artificial intelligence (AI), which play a crucial role in enhancing the efficiency and accuracy of biopsy analysis. AI-powered software assists pathologists by expediting the evaluation of biopsy results, thereby streamlining the diagnostic process and minimizing delays. With AI's ability to digitize pathology slides, pathologists can conveniently share images with specialists for remote consultations, bridging the gap in areas with limited access to pathology services. This connectivity fosters collaboration and enhances the quality of care, ultimately stimulating growth within the global skin biopsy market through improved diagnostic capabilities and accessibility.

Restraints in the Global Skin Biopsy Market

The global skin biopsy market faces significant restraints primarily due to the financial implications associated with biopsy procedures. The costs incurred from pre-operative assessments to post-operative care pose a considerable challenge to market expansion. Individuals with low or moderate incomes find these procedures prohibitively expensive, particularly in healthcare systems with limited budgets. Consequently, those without adequate insurance coverage often face barriers, effectively creating unequal access to vital diagnostic services. This financial strain can lead to delays in obtaining necessary biopsies or result in missed diagnoses, exacerbating healthcare disparities. Addressing these financial inequalities is essential for promoting equitable healthcare access and stimulating market growth.

Market Trends of the Global Skin Biopsy Market

The Global Skin Biopsy market is experiencing a notable upward trend, driven by the increasing adoption of integrated biopsy techniques within healthcare settings. Hospitals are leveraging advanced diagnostic technologies, such as image-guided biopsies, endoscopic methods, and molecular analysis, to enhance the accuracy of tissue sample assessments. Institutions like Texas Children's Hospital and United Hospital Central West Virginia exemplify this shift towards holistic approaches that provide comprehensive insights into pathology. As clinicians embrace these integrated methodologies to refine diagnostic capabilities and optimize patient care, demand for biopsy devices is projected to surge, signaling robust growth potential in the skin biopsy market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Skin Biopsy Market Size by Type & CAGR (2025-2032)

• Market Overview
• Shave Biopsy
• Punch Biopsy
• Excisional Biopsy

Global Skin Biopsy Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Skin Cancer
• Actinic Keratosis
• Dermatitis
• Others

Global Skin Biopsy Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Clinics
• Diagnostic Laboratories
• Other

Global Skin Biopsy Market Size & CAGR (2025-2032)

• North America (Type, Indication, End User)
  • US
  • Canada
• Europe (Type, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems Nussloch GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innovia Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DTR Medical Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gallini Srl (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KAI Group (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AccuTec, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomarker Technologies (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vernacare (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Freenome Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biodesix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GRAIL, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations